Ureteropelvic Junction Obstruction with a Simultaneous Renal Calculus: Long-Term Followup

Douglas A. Husmann, Dawn S. Milliner, Joseph W. Segura

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

We reviewed 111 patients who presented with simultaneous renal calculi and a ureteropelvic junction obstruction. Of 34 patients with ureteropelvic junction obstruction and a coexisting struvite stone 62 percent had recurrent calculi. The use of antibiotics significantly affected the incidence of recurrent struvite calculi. In particular, if prolonged prophylactic antibiotics (greater than 3 months) were used 15 percent of the patients had recurrent stones, compared to 90 percent if only perioperative antibiotics (less than 15 days) were used (p less than 0.001). Patients with ureteropelvic junction obstruction and coexisting nonstruvite calculi were treated by either observation alone (53) or metabolic evaluation with appropriate intervention (24). Metabolic evaluation of patients with nonstruvite calculi revealed that 76 percent had an identifiable metabolic abnormality, treatment of which significantly decreased the incidence of recurrent renal calculi: 17 percent of the patients on interventional therapy had recurrent stones compared to 55 percent treated by observation alone (p less than 0.001).

Original languageEnglish (US)
Pages (from-to)1399-1402
Number of pages4
JournalThe Journal of Urology
Volume153
Issue number5
DOIs
StatePublished - 1995

Fingerprint

Kidney Calculi
Calculi
Anti-Bacterial Agents
Observation
Incidence
Therapeutics

ASJC Scopus subject areas

  • Urology

Cite this

Ureteropelvic Junction Obstruction with a Simultaneous Renal Calculus : Long-Term Followup. / Husmann, Douglas A.; Milliner, Dawn S.; Segura, Joseph W.

In: The Journal of Urology, Vol. 153, No. 5, 1995, p. 1399-1402.

Research output: Contribution to journalArticle

Husmann, Douglas A. ; Milliner, Dawn S. ; Segura, Joseph W. / Ureteropelvic Junction Obstruction with a Simultaneous Renal Calculus : Long-Term Followup. In: The Journal of Urology. 1995 ; Vol. 153, No. 5. pp. 1399-1402.
@article{310e65e705d64dcd8b2409599a199115,
title = "Ureteropelvic Junction Obstruction with a Simultaneous Renal Calculus: Long-Term Followup",
abstract = "We reviewed 111 patients who presented with simultaneous renal calculi and a ureteropelvic junction obstruction. Of 34 patients with ureteropelvic junction obstruction and a coexisting struvite stone 62 percent had recurrent calculi. The use of antibiotics significantly affected the incidence of recurrent struvite calculi. In particular, if prolonged prophylactic antibiotics (greater than 3 months) were used 15 percent of the patients had recurrent stones, compared to 90 percent if only perioperative antibiotics (less than 15 days) were used (p less than 0.001). Patients with ureteropelvic junction obstruction and coexisting nonstruvite calculi were treated by either observation alone (53) or metabolic evaluation with appropriate intervention (24). Metabolic evaluation of patients with nonstruvite calculi revealed that 76 percent had an identifiable metabolic abnormality, treatment of which significantly decreased the incidence of recurrent renal calculi: 17 percent of the patients on interventional therapy had recurrent stones compared to 55 percent treated by observation alone (p less than 0.001).",
author = "Husmann, {Douglas A.} and Milliner, {Dawn S.} and Segura, {Joseph W.}",
year = "1995",
doi = "10.1016/S0022-5347(01)67412-3",
language = "English (US)",
volume = "153",
pages = "1399--1402",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Ureteropelvic Junction Obstruction with a Simultaneous Renal Calculus

T2 - Long-Term Followup

AU - Husmann, Douglas A.

AU - Milliner, Dawn S.

AU - Segura, Joseph W.

PY - 1995

Y1 - 1995

N2 - We reviewed 111 patients who presented with simultaneous renal calculi and a ureteropelvic junction obstruction. Of 34 patients with ureteropelvic junction obstruction and a coexisting struvite stone 62 percent had recurrent calculi. The use of antibiotics significantly affected the incidence of recurrent struvite calculi. In particular, if prolonged prophylactic antibiotics (greater than 3 months) were used 15 percent of the patients had recurrent stones, compared to 90 percent if only perioperative antibiotics (less than 15 days) were used (p less than 0.001). Patients with ureteropelvic junction obstruction and coexisting nonstruvite calculi were treated by either observation alone (53) or metabolic evaluation with appropriate intervention (24). Metabolic evaluation of patients with nonstruvite calculi revealed that 76 percent had an identifiable metabolic abnormality, treatment of which significantly decreased the incidence of recurrent renal calculi: 17 percent of the patients on interventional therapy had recurrent stones compared to 55 percent treated by observation alone (p less than 0.001).

AB - We reviewed 111 patients who presented with simultaneous renal calculi and a ureteropelvic junction obstruction. Of 34 patients with ureteropelvic junction obstruction and a coexisting struvite stone 62 percent had recurrent calculi. The use of antibiotics significantly affected the incidence of recurrent struvite calculi. In particular, if prolonged prophylactic antibiotics (greater than 3 months) were used 15 percent of the patients had recurrent stones, compared to 90 percent if only perioperative antibiotics (less than 15 days) were used (p less than 0.001). Patients with ureteropelvic junction obstruction and coexisting nonstruvite calculi were treated by either observation alone (53) or metabolic evaluation with appropriate intervention (24). Metabolic evaluation of patients with nonstruvite calculi revealed that 76 percent had an identifiable metabolic abnormality, treatment of which significantly decreased the incidence of recurrent renal calculi: 17 percent of the patients on interventional therapy had recurrent stones compared to 55 percent treated by observation alone (p less than 0.001).

UR - http://www.scopus.com/inward/record.url?scp=0028970147&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028970147&partnerID=8YFLogxK

U2 - 10.1016/S0022-5347(01)67412-3

DO - 10.1016/S0022-5347(01)67412-3

M3 - Article

C2 - 7714950

AN - SCOPUS:0028970147

VL - 153

SP - 1399

EP - 1402

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 5

ER -